Schroder Investment Management Group
NVAX icon

Schroder Investment Management Group’s Novavax NVAX Stock Holding History

Schroder Investment Management Group’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-53,836
Closed -$4.02M – 1365
2022
Q1 		$4.02M Buy
53,836
+2,011
+4% +$179K 0.01% 890
2021
Q4 		$7.42M Sell
51,825
-15,363
-23% -$2.64M 0.01% 665
2021
Q3 		$13.9M Sell
67,188
-59,191
-47% -$13M 0.02% 555
2021
Q2 		$26.8M Buy
126,379
+12,093
+11% +$2.22M 0.03% 451
2021
Q1 		$20.7M Sell
114,286
-51,955
-31% -$10.4M 0.03% 493
2020
Q4 		$18.5M Buy
166,241
+14,162
+9% +$1.51M 0.03% 502
2020
Q3 		$15.8M Buy
152,079
+110,591
+267% +$13.5M 0.03% 485
2020
Q2 		$3.46M Buy
+41,488
New +$1.59M 0.01% 727

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Voloridge Investment Management
Voloridge Investment Management Jupiter, Florida $25B AUM 28.08% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Schroder Investment Management Group's NVAX Position: Q2 2022 in Review

Schroder Investment Management Group sold out of Novavax (NVAX) in Q2 2022, closing a stake of 53,836 shares — an estimated $4.02M sold.

Schroder Investment Management Group first reported a position in NVAX in Q2 2020 and held it in 8 quarters. The position peaked at $26.8M in Q2 2021. 325 funds tracked by Wall St. Rank hold NVAX as of Q2 2022.

  • Schroder Investment Management Group reported no remaining Novavax position as of Q2 2022 after selling out during the quarter.
  • Schroder Investment Management Group sold 53,836 Novavax shares in Q2 2022, an estimated $4.02M.
  • Schroder Investment Management Group first reported a position in Novavax in Q2 2020 and held it in 8 quarters.
  • Schroder Investment Management Group's Novavax position peaked at $26.8M in Q2 2021.
  • 325 funds tracked by Wall St. Rank held Novavax as of Q2 2022.

Based on Schroder Investment Management Group's 13F filing for Q2 2022, filed 11 Aug 2022.